Upgrade to SI Premium - Free Trial

Amylyx Pharmaceuticals (AMLX)

13.32 -0.99 (6.92%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/6/26)

Latest Headlines

Form 8-K Amylyx Pharmaceuticals, For: Jun 04 June 4, 2026 4:07 PM - SEC Filing Form 4 Amylyx Pharmaceuticals, For: May 21 Filed by: Firestone Karen May 26, 2026 4:03 PM - SEC Filing Form SCHEDULE 13G/A Amylyx Pharmaceuticals, Filed by: PERCEPTIVE ADVISORS LLC May 15, 2026 4:00 PM - SEC Filing Amylyx publishes phase 2 trial data for Wolfram syndrome treatment May 15, 2026 12:12 PM - StreetInsider Amylyx Pharmaceuticals Announces Peer-Reviewed Publication of Phase 2 Open-Label HELIOS Trial Data for AMX0035 in The Journal of Clinical Investigation May 15, 2026 12:12 PM - BizWire Form 10-Q Amylyx Pharmaceuticals, For: Mar 31 May 7, 2026 7:05 AM - SEC Filing Form 8-K Amylyx Pharmaceuticals, For: May 07 May 7, 2026 7:03 AM - SEC Filing Amylyx Pharmaceuticals, Inc. (AMLX) Misses Q1 EPS by 4c May 7, 2026 7:00 AM - StreetInsider Amylyx Pharmaceuticals Reports First Quarter 2026 Financial Results May 7, 2026 7:00 AM - BizWire Amylyx Pharmaceuticals to Participate in Upcoming Investor Conferences May 6, 2026 9:00 AM - BizWire Amylyx launches expanded access program for post-bariatric hypoglycemia drug May 5, 2026 7:01 AM - StreetInsider Amylyx Pharmaceuticals Announces U.S. Expanded Access Program for Adults with Post-Bariatric Hypoglycemia May 5, 2026 7:00 AM - BizWire Amylyx Pharmaceuticals to Report First Quarter 2026 Financial Results on May 7, 2026 April 30, 2026 9:00 AM - BizWire Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $22 at BofA Securities April 28, 2026 12:18 PM - StreetInsider Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $21 at Mizuho, 'a current top pick' April 28, 2026 6:35 AM - StreetInsider Form ARS Amylyx Pharmaceuticals, For: Dec 31 April 23, 2026 7:04 AM - SEC Filing Form DEFA14A Amylyx Pharmaceuticals, April 23, 2026 7:04 AM - SEC Filing Form DEF 14A Amylyx Pharmaceuticals, For: Jun 04 April 23, 2026 7:04 AM - SEC Filing Amylyx Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference April 8, 2026 9:01 AM - BizWire Form SCHEDULE 13G/A Amylyx Pharmaceuticals, Filed by: VANGUARD GROUP INC March 26, 2026 3:42 PM - SEC Filing H.C. Wainwright Reiterates Buy Rating on Amylyx Pharmaceuticals inc. (AMLX) March 25, 2026 6:57 AM - StreetInsider Form 8-K Amylyx Pharmaceuticals, For: Mar 24 March 24, 2026 7:11 AM - SEC Filing Amylyx completes enrollment in phase 3 trial for post-bariatric hypoglycemia March 24, 2026 7:00 AM - StreetInsider Amylyx Pharmaceuticals Announces Completion of Enrollment in Pivotal Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia March 24, 2026 7:00 AM - BizWire Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $30 at Guggenheim March 19, 2026 6:12 AM - StreetInsider Form 4 Amylyx Pharmaceuticals, For: Mar 05 Filed by: Mazzariello Gina March 9, 2026 4:00 PM - SEC Filing Form 4 Amylyx Pharmaceuticals, For: Mar 05 Filed by: FRATES JAMES M March 9, 2026 4:00 PM - SEC Filing Form 4 Amylyx Pharmaceuticals, For: Mar 05 Filed by: Cohen Joshua B March 9, 2026 4:00 PM - SEC Filing Form 4 Amylyx Pharmaceuticals, For: Mar 05 Filed by: Bedrosian Camille L March 9, 2026 4:00 PM - SEC Filing Form 4 Amylyx Pharmaceuticals, For: Mar 05 Filed by: Klee Justin B. March 9, 2026 4:00 PM - SEC Filing Full Article List